Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines
Authors:
Open Access
- 12 June 2015
- journal article
- pharmacokinetics and-disposition
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 71 (8) , 979-990
Abstract
To date, the interchangeability of generic drugs has only been investigated for a limited number of medicines. The objective of this study was to investigate generic-generic drug interchangeability in a large subset of generic formulations in order to cover a broad spectrum of drugs.Keywords
This publication has 31 references indexed in Scilit:
- Clinical Equivalence of Proprietary and Generic Atorvastatin in Lipid Clinic PatientsCanadian Journal of Cardiology, 2013
- Statins: Is It Safe and Effective to Use Generic “Equivalents”?Canadian Journal of Cardiology, 2013
- Evaluation of Clinical and Safety Outcomes Associated with Conversion from Brand‐Name to Generic Tacrolimus in Transplant Recipients Enrolled in an Integrated Health Care SystemPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Bioequivalence Requirements in the European Union: Critical DiscussionThe AAPS Journal, 2012
- Generic Immunosuppression in Solid Organ TransplantationTransplantation, 2012
- A Multicenter Experience With Generic Tacrolimus ConversionTransplantation, 2011
- Generic Immunosuppressants in Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2011
- Generic products of antiepileptic drugs: A perspective on bioequivalence and interchangeabilityEpilepsia, 2010
- Bioequivalence testing of immunosuppressants: concepts and misconceptionsKidney International, 2010
- Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: Four open-label, randomized crossover trials in healthy volunteersClinical Therapeutics, 2009